Target intelligence / Profile preview

DAZ-associated protein 1 (DAZAP1)

Target
DAZAP1
Molecular classification
Heterogeneous nuclear ribonucleoprotein (hnRNP) protein, RNA-binding protein, Splicing factor
01

Overview

DAZ-associated protein 1 (DAZAP1) is a member of the hnRNP family of RNA-binding proteins that is highly conserved across vertebrates[1][2]. DAZAP1 contains two N-terminal RNA recognition motif (RRM) domains and a low-complexity, proline-rich C-terminal domain that is important for splicing regulation and protein-protein interactions[1][2]. It was originally identified as a binding partner for DAZ (deleted in azoospermia), a factor implicated in human male infertility[1]. DAZAP1 shuttles between the nucleus and cytoplasm depending on cell type and external signals[2][3]. Its primary function is in the regulation of alternative splicing for hundreds of endogenous gene transcripts, many of which are involved in cell growth, phosphorylation signaling cascades, and energy metabolism[1][2]. DAZAP1 activity is tightly controlled by phosphorylation via the MEK/Erk pathway, which influences its localization and splicing function[1][2]. Knockout of DAZAP1 in mice leads to developmental arrest, smaller body size, premature death, and spermatogenic failure, underscoring its essential role[1][3]. DAZAP1 is not known to be directly targeted by any approved drugs, and there are no clinical biomarkers or safety concerns associated with targeting DAZAP1, as it is not a conventional therapeutic target[1][2][3].

Other names
DAZAP1Deleted in azoospermia-associated protein 1MGC19907Testicular tissue protein Li 50DAZ associated protein 1DAZAP1_X2
02

Biological functions

Alternative splicing regulationCell proliferationmRNA localizationmRNA transportRegulation of gene transcriptionSpermatogenesisEnergy metabolism (indirectly via regulated targets)Fibroblast proliferation
03

Disease associations

Spermatogenic failure (male infertility, due to “deleted in azoospermia”)Potential role in cancer: Involvement in chromosomal translocations with MEF2D in pre-B acute lymphoblastic leukemia; MEF2D/DAZAP1 fusion may promote cell growthAberrant splicing in cancer-related genes (e.g., BRCA1)Possible link to general cell proliferation and growth disorders

Beyond the preview

Go deeper on DAZ-associated protein 1 (DAZAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DAZ-associated protein 1 (DAZAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call